Incidence of herpes zoster and associated events including stroke-a population-based cohort study

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Sundström, Karin ^a   Weibull, Caroline E ^a   Söderberg Löfdal, Karin ^a   Bergström, Tomas ^b   Sparén, Pär ^a   Arnheim Dahlström, Lisen ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cohort; Herpes zoster; Incidence; Sepsis; Stroke

Indexed keywords

ANALGESIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; EYE DISEASE; FEMALE; FOLLOW UP; HERPES ZOSTER; HERPES ZOSTER ENCEPHALITIS; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; SEPSIS; SEX RATIO; SWEDEN; COMPLICATION; ECONOMICS; IMMUNOLOGY; MIDDLE AGED; NEURALGIA, POSTHERPETIC; NEWBORN; PRESCHOOL CHILD; REGISTER; STROKE; VARICELLA ZOSTER VIRUS; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; REGISTRIES; SEPSIS; STROKE; SWEDEN; YOUNG ADULT;

EID: 84946489367     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1170-y     Document Type: Article

References (35)

1. Bowsher D. The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: A retrospective survey in an elderly population. Eur J Pain. 1999;3:335-42.
2. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127:305-14.
3. Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014;371:1526-33.
4. Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792-7.
5. Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40:3443-8.
6. Gilden D, Nagel MA, Mahalingam R, Mueller NH, Brazeau EA, Pugazhenthi S, et al. Clinical and molecular aspects of varicella zoster virus infection. Future Neurol. 2009;4:103-17.
7. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108, E79.
8. Parment PA, Svahn A, Ruden U, Brakenhielm G, Storsaeter J, Akesson L, et al. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12years of age. Scand J Infect Dis. 2003;35:736-42.
9. WHO. Varicella and herpes zoster vaccines: WHO position paper. Weekly Epidemiological Record (WER). 2014;89:265-88.
10. Esteban-Vasallo MD, Gil-Prieto R, Dominguez-Berjon MF, Astray-Mochales J, Gil De Miguel A. Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005-2012. J Infect. 2014;68(4):378-86.
11. Wu PY, Wu HD, Chou TC, Sung FC. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PloS one. 2013;8:e77709.
12. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81:928-30.
13. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341-9.
14. Studahl M, Petzold M, Cassel T. Disease burden of herpes zoster in Sweden--predominance in the elderly and in women - a register based study. BMC Infect Dis. 2013;13:586.
15. Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V. A population based study of the epidemiology of Herpes Zoster and its complications. J Infect. 2013;67:463-9.
16. Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. Bmj. 2014;348:g2911.
17. Persson A, Bergstrom T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol. 2009;46:249-53.
18. Brisson M, Edmunds WJ. Epidemiology of Varicella-Zoster Virus in England and Wales. J Med Virol. 2003;70 Suppl 1:S9-14.
19. Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL, et al. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013;22:82-90.
20. Allwinn RB, S Doerr HW. Epidemiology of Herpes Zoster: What has Changed? Monographs Virol. 2006;26:154-63.
21. Yawn BP. Post-shingles neuralgia by any definition is painful, but is it PHN? Mayo Clinic proceedings. 2011;86:1141-2.
22. Läkemedelsverket. Treatment Recommendation: Pharmacotherapy for herpes simplex, varicella- and herpes zoster infections. Vol. 4, 2005:34-47.
23. Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001;19:3076-90.
24. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract. 1975;25:571-5.
25. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350-4.
26. Nagel MA, Mahalingam R, Cohrs RJ, Gilden D. Virus vasculopathy and stroke: an under-recognized cause and treatment target. Infect Disord Drug Targets. 2010;10:105-11.
27. Nagel M, Ortiz GA. Does herpes zoster ophthalmicus increase the risk of stroke? Neurology. 2010;74:788-9.
28. Askalan R, Laughlin S, Mayank S, Chan A, MacGregor D, Andrew M, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke. 2001;32:1257-62.
29. Miravet E, Danchaivijitr N, Basu H, Saunders DE, Ganesan V. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol. 2007;49:417-22.
30. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol. 2003;53:167-73.
31. Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child. 2007;92:1062-6.
32. Pollard AJ, Isaacs A, Hermione Lyall EG, Curtis N, Lee K, Walters S, et al. Potentially lethal bacterial infection associated with varicella zoster virus. Bmj. 1996;313:283-5.
33. Yawn BP, Wollan P, St SJ. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol. 2011;174:1054-61.
34. Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc. 2009;84:787-94.
35. Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.